Isis Pharma's diabetes drug takes longer-than-expected to work

February 3, 2015 12:18 PM

12 0

(Reuters) - Isis Pharmaceuticals Inc's experimental diabetes drug took a longer-than-expected 36 weeks to reduce blood sugar levels in patients with type 2 diabetes.

The mid-stage study had aimed to prove that a 200 mg dose of the drug taken over 26 weeks would work better than a placebo on 92 patients suffering from uncontrolled blood sugar, despite treatment.

Read more

To category page